The Amlodipine/Telmisartan Shortage: Where Things Stand in 2026

If you rely on Amlodipine/Telmisartan to keep your blood pressure under control, the past couple of years have probably been frustrating. Between the discontinuation of Twynsta, inconsistent generic supply, and pharmacies not routinely stocking the combination, many patients have been left wondering: Is there actually a shortage, or is my pharmacy just not carrying it?

The answer is a bit of both. Let's break down the current situation.

Is Amlodipine/Telmisartan Still in Shortage?

The FDA has listed Telmisartan and Amlodipine (Twynsta) tablets under a "Discontinuation" status — meaning the brand-name product is no longer being manufactured. However, this doesn't mean the medication is gone. Generic versions of Amlodipine/Telmisartan are still produced and available.

The reality in 2026 is that the combination tablet isn't technically in a widespread national shortage. Rather, it's experiencing intermittent availability issues — some pharmacies have it, some don't, and it can vary week to week. This patchwork availability feels like a shortage to the patients who can't find it.

Why Is Amlodipine/Telmisartan Hard to Find?

Several factors are making this medication harder to locate than it should be:

• Twynsta discontinuation: When Boehringer Ingelheim stopped making the brand-name product, not all pharmacies smoothly transitioned to stocking the generic combination.
• Limited generic manufacturers: Fewer companies make the Amlodipine/Telmisartan combination compared to the individual drugs. This means any production disruption at one manufacturer has an outsized impact.
• Lower demand signals: Because the combination isn't as widely prescribed as, say, Amlodipine alone (one of the most prescribed drugs in the U.S.), pharmacy inventory systems may not prioritize keeping it in stock.
• Supply chain strain: Ongoing challenges with pharmaceutical raw materials, inspections, and shipping logistics can create regional and temporary shortages.

For a deeper explanation, read why Amlodipine/Telmisartan is so hard to find.

How Much Does Amlodipine/Telmisartan Cost in 2026?

Cost is a real concern, especially for patients without insurance or with high-deductible plans. Here's what you can expect:

• Retail cash price: $120 to $250 for a 30-day supply (varies by strength and pharmacy)
• With GoodRx coupon: Starting around $123
• With SingleCare coupon: Around $141
• Taking the drugs separately: Generic Amlodipine ($3-$10/month) + generic Telmisartan ($15-$30/month) = roughly $18 to $40/month total

For a complete breakdown of savings options, visit our guide to saving money on Amlodipine/Telmisartan.

Are There New Options in 2026?

A few developments are worth knowing about:

• Widaplik (Telmisartan/Amlodipine/Indapamide): In late 2025, the FDA approved this triple-combination pill from George Medicines. It contains Telmisartan, Amlodipine, and Indapamide (a diuretic) in a single tablet. It's the first triple-combination of its kind and may be an option for patients who need additional blood pressure control. Talk to your doctor about whether it's appropriate for you.
• More generic competition: As more manufacturers see demand for the ARB + CCB combination space, additional generic options may become available, helping stabilize supply.

How to Find Amlodipine/Telmisartan in Stock

If you need to fill your prescription right now, here's your action plan:

1. Check Medfinder — search for pharmacies near you with Amlodipine/Telmisartan in stock.
2. Call independent pharmacies — they often have more flexible ordering options. Learn how to check pharmacy stock.
3. Ask your pharmacist to special-order — most pharmacies can get medications within 1-2 business days.
4. Consider mail-order — mail-order pharmacies often have better inventory for maintenance medications.
5. Ask your doctor about alternatives — if you can't find the combination, similar medications like Valsartan/Amlodipine or Olmesartan/Amlodipine are more widely available.

Final Thoughts

The Amlodipine/Telmisartan supply situation in 2026 is a frustrating mix of brand discontinuation, limited generic makers, and inconsistent pharmacy stocking. It's not a true nationwide shortage, but the practical effect for patients is the same: it can be hard to find when you need it.

Stay proactive. Use tools like Medfinder to locate pharmacies with stock, plan your refills ahead, and have a conversation with your doctor about backup options. Your blood pressure control is too important to let supply chain issues get in the way.